How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

PM

NASDAQ:PMCB
Get a brief AI stock analysisSaves ~ 15 minutes of your time

PM

PharmaCyte Biotech IncNASDAQ PMCB Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is PMCB undervalued compared to its fair value?

The fair value of PMCB stock is hidden USD. Relative to the market price of 1.96 USD PharmaCyte Biotech Inc is hidden.

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. The company is headquartered in Laguna Hills, California a...[More about valuation]

PharmaCyte Biotech Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.017 $B

Price:

1.96 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.258

FINANCIALS

PharmaCyte Biotech financial for reporting period

Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0014 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0023 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

Balance Sheet

0.079 B
0.058 B

Financial Position Analysis

Assets

0.079 B
Current Assets
0.074 B
Total non-current assets
0.0051 B

Total current liabilities
0.0052 B
Total non-current liabilities
0.016 B

Cash Flow Statement

-0.002 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.002 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

PharmaCyte Biotech fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is PMCB attractive for investment based on fundamental analysis?

PMCB stock rating is hidden. PharmaCyte Biotech is a hidden by Eyestock methodology.

Get PMCB Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

PMCB analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for PMCB to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

PharmaCyte Biotech Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

PharmaCyte Biotech Inc dividends

PMCB dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About PMCB stock

About the company PharmaCyte Biotech Inc

Market cap $B

0.017

Dividend yield

Shares outstanding

17.4434 B

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. The company is headquartered in Laguna Hills, California and currently employs 4 full-time employees. The company went IPO on 2003-09-11. The firm is focused on developing and preparing to commercialize cellular therapies for cancer, diabetes and malignant ascites based upon its cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The company is advancing clinical research and development of new cellular-based therapies in oncology and diabetes. The Cell-in-a-Box encapsulation technology enables genetically engineered live human cells to be used to produce various biologically active molecules. Its current generation of product candidates is referred to as CypCaps. The company is developing therapies for pancreatic and other solid cancerous tumours by using genetically engineered live human cells. Its product candidate for the treatment of diabetes consists of encapsulated, genetically modified insulin-producing cells. The firm is also developing therapies for cancer that involve prodrugs based upon certain constituents of the cannabis plant.

PMCB profile

  • Ticker

    PMCB

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    11 September 2003

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    4

  • City

    Laguna Hills

  • Address

    23046 Avenida De La Carlota, Suite 600

  • Cusip

    71715X203